(Q33738090)

29 July 2017

1 reference

title

Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice (English)

1 reference

29 July 2017

Burke MJ

1

1 reference

PubMed ID

10496302

29 July 2017

Preskorn SH

series ordinal

2

1 reference

29 July 2017

1 August 1999

1 reference

Clinical Pharmacokinetics

29 July 2017

1 reference

29 July 2017

37

1 reference

29 July 2017

2

1 reference

29 July 2017

147-165

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199937020-00004

29 July 2017

0 references

cites work

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

1 reference

12 December 2020

Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine

1 reference

12 December 2020

Trends in the prescription of antidepressants by office-based psychiatrists

1 reference

12 December 2020

Antidepressant drug selection: criteria and options.

1 reference

12 December 2020

Human brain fluoxetine concentrations.

1 reference

12 December 2020

Electrocardiogram changes and plasma desipramine levels during treatment of depression

1 reference

12 December 2020

The pharmacokinetics of paroxetine in the elderly

1 reference

12 December 2020

Bupropion in depression. II. The role of metabolites in clinical outcome

1 reference

12 December 2020

Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness

1 reference

12 December 2020

Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo

1 reference

12 December 2020

DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity.

1 reference

12 December 2020

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration

1 reference

12 December 2020

Pharmacology of antidepressants--characteristics of the ideal drug

1 reference

12 December 2020

Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels

1 reference

12 December 2020

Dosing of antidepressants--the unknown art

1 reference

12 December 2020

The kinetics of citalopram: single and multiple dose studies in man

1 reference

12 December 2020

The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis

1 reference

12 December 2020

Satisfaction, compliance and communication

1 reference

12 December 2020

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

12 December 2020

Therapeutic drug monitoring of tricyclic antidepressants: a standard of care issue.

1 reference

12 December 2020

Blood levels and acute response to bupropion

1 reference

12 December 2020

Chronological milestones to guide drug change. When should clinicians switch antidepressants?

1 reference

12 December 2020

Selection of an antidepressant: mirtazapine

1 reference

12 December 2020

Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite

1 reference

12 December 2020

Seizures and bupropion: a review

1 reference

12 December 2020

Kinetics of citalopram in man; plasma levels in patients

1 reference

12 December 2020

Paroxetine: Pharmacokinetics, Tolerance and Depletion of Blood 5-HT in Man

1 reference

12 December 2020

Paroxetine: pharmacokinetic and antidepressant effect in the elderly

1 reference

12 December 2020

Therapeutic drug monitoring. Principles and practice

1 reference

12 December 2020

What constitutes an adequate antidepressant trial for fluoxetine?

1 reference

12 December 2020

Paroxetine plasma levels: lack of correlation with efficacy or adverse events

1 reference

12 December 2020

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

1 reference

12 December 2020

Pharmacokinetics of antidepressants: why and how they are relevant to treatment

1 reference

12 December 2020

High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data

1 reference

12 December 2020

Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine

1 reference

12 December 2020

Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats.

1 reference

12 December 2020

Pharmacokinetics of second generation antidepressants: fluoxetine

1 reference

12 December 2020

Tricyclic antidepressant-induced seizures and plasma drug concentration

1 reference

12 December 2020

Effect of dose escalation after low-dose fluoxetine therapy

1 reference

12 December 2020

Recent developments in the pharmacotherapy of mood disorders

1 reference

12 December 2020

Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a "therapeutic window"?

1 reference

12 December 2020

Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring

1 reference

12 December 2020

Low-dose fluoxetine therapy for depression

1 reference

12 December 2020

Serum fluoxetine and norfluoxetine concentrations and antidepressant response

1 reference

12 December 2020

Desipramine: cardiovascular effects and plasma levels

1 reference

12 December 2020

Pharmacokinetic optimisation of therapy with newer antidepressants

1 reference

12 December 2020

The role of the primary care physician in patients' adherence to antidepressant therapy.

1 reference

12 December 2020

Should bupropion dosage be adjusted based upon therapeutic drug monitoring?

1 reference

12 December 2020

Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection

1 reference

12 December 2020

Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography

1 reference

12 December 2020

Changes in human whole blood 5-hydroxytryptamine (5-HT) and platelet 5-HT uptake during treatment with paroxetine, a selective 5-HT uptake inhibitor.

1 reference

12 December 2020

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

1 reference

12 December 2020

Plasma levels of imipramine and adverse effects in children

1 reference

12 December 2020

Fluoxetine versus trazodone: efficacy and activating-sedating effects

1 reference

12 December 2020

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

1 reference

12 December 2020

Psychotropic blood levels: a guide to clinical response.

1 reference

12 December 2020

Optimal dose regimen for paroxetine

1 reference

12 December 2020

Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders

1 reference

12 December 2020

Unsuccessful suicide attempt by sertraline overdose

1 reference

12 December 2020

Therapeutic drug monitoring of bupropion

1 reference

12 December 2020

Somatic therapy for major depressive disorder: selection of an antidepressant

1 reference

12 December 2020

Pharmacokinetics of second generation antidepressants: bupropion

1 reference

12 December 2020

Fixed-dose fluoxetine therapy for depression

1 reference

12 December 2020

A pharmacokinetic dose titration study in adult and elderly depressed patients

1 reference

12 December 2020

Kinetic-dynamic modeling in clinical psychopharmacology

1 reference

12 December 2020

Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?

1 reference

12 December 2020

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine

1 reference

12 December 2020

The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression

1 reference

12 December 2020

What to do about extremely high plasma levels of tricyclics?

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder.

1 reference

12 December 2020

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

10.2165/00003088-199937020-00004

Identifiers

DOI

1 reference

PubMed ID

10496302

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10496302